Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natrecor for Cardio-Renal Decompensation Syndrome
NCT00186329Phase 4Completed
- Sponsor
- Stanford University
- Start
- Mar 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in heart failure (HF) and Renal Insufficiency (RI) comparing Natrecor with Placebo (2 arms). Primary endpoints: Prevention of worsened renal dysfunction and Change in serum creatinine at 7 days. Started Mar 2004; status: completed.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)Renal Insufficiency (RI)
Beyond the preview
Go deeper on NCT00186329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00186329.